Tag: Risk and benefit
-
The risk-benefit argument

Below is an excerpt of longer form research, which can be found here. Introduction: On the 10th July 2021, a risk-benefit analysis for people aged under 60 in Australia investigated TTS following AstraZeneca: “For the current situation of low incidence of COVID-19, the risk of fatality from possible TTS or serious morbidity such as stroke…